Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 90,679 | 85,485 | 67,602 | 92,432 | 86,451 |
| Cost of Goods | 73,699 | 71,685 | 51,276 | 74,869 | 71,606 |
| Gross Profit | 16,980 | 13,800 | 16,326 | 17,563 | 14,845 |
| Operating Expenses | 9,586 | 10,868 | 7,359 | 11,174 | 11,352 |
| Operating Income | 8,093 | 3,617 | 9,243 | 7,258 | 4,099 |
| Interest Expense | 1,761 | 1,642 | 1,843 | 1,857 | 1,927 |
| Pre-tax Income | 6,332 | 1,975 | 7,400 | 5,401 | 2,172 |
| Income Tax | 1,663 | 557 | 2,432 | 2,269 | 912 |
| Net Income Continuous | 4,669 | 1,418 | 4,968 | 3,132 | 1,260 |
| Net Income Discontinuous | -34 | -261 | N/A | N/A | N/A |
| Net Income | $4,635 | $1,157 | $3,004 | $3,132 | $1,260 |
| EPS Basic Total Ops | 0.08 | 0.02 | 0.05 | 0.05 | 0.02 |
| EPS Basic Continuous Ops | 0.08 | 0.03 | 0.07 | 0.05 | 0.02 |
| EPS Basic Discontinuous Ops | 0.00 | -0.01 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.08 | 0.02 | 0.05 | 0.05 | 0.02 |
| EPS Diluted Continuous Ops | 0.08 | 0.03 | 0.07 | 0.05 | 0.02 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.01 | N/A | N/A | N/A |
| EBITDA(a) | $12,675 | $8,058 | $11,392 | $12,516 | $4,099 |